• Home

NY AG Extends Naloxone Rebate With Manufacturer

By FOX 40 Staff.
A reduced pricing agreement for naloxone between the State of New York and Amphastar Pharmaceuticals has been extended.

Attorney General Eric Schneiderman has announced an agreement with Amphastar Pharmaceuticals, Inc. to extend a price cut the highly effective antidote that can quickly reverse an opioid overdose, for all agencies in New York State for the next year.

The terms of the contract say that Amphastar will cover a $6 rebate per dose, which will also automatically increase, dollar-for-dollar, to match future growth in the wholesale price. Additionally, this rebate is available not only to the Office of the Attorney General, but also all public entities, including but not limited to the State Department of Health, the City of New York, the governments of individual New York Counties, and the drug treatment centers and harm reduction programs they fund.

Tuesday’s agreement extends the same agreement made last year for another one year period. Overall, the deal reduces the price of naloxone by nearly 20 percent. The rebate applies even if the purchasing agency separately negotiated a discount below the published wholesale rate, and regardless of whether the agency buys from Amphastar or a third party. Last year’s agreement served as a national model that was adopted by other states, including Delaware, Ohio, and Rhode Island.

“The price reduction announced today will save lives and help agencies across New York fight the scourge of heroin abuse,” said Attorney General Schneiderman. “Thousands of lives have been saved as a result of the use of naloxone, and it is my hope that getting this powerful, opiod antidote in the hands of more agencies will give those struggling with addiction a second chance at life and sobriety.”